AU2003245750A1 - Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator - Google Patents

Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator

Info

Publication number
AU2003245750A1
AU2003245750A1 AU2003245750A AU2003245750A AU2003245750A1 AU 2003245750 A1 AU2003245750 A1 AU 2003245750A1 AU 2003245750 A AU2003245750 A AU 2003245750A AU 2003245750 A AU2003245750 A AU 2003245750A AU 2003245750 A1 AU2003245750 A1 AU 2003245750A1
Authority
AU
Australia
Prior art keywords
immunomodulator
oxidised cellulose
polyanhydroglucuronic acid
microdispersed
microdispersed oxidised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003245750A
Inventor
Jiri Briestensky
Marketa Jelinkova
Blanka Rihova
Ivan Santar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpenstock Holdings Ltd
Original Assignee
Alpenstock Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpenstock Holdings Ltd filed Critical Alpenstock Holdings Ltd
Publication of AU2003245750A1 publication Critical patent/AU2003245750A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2003245750A 2002-02-14 2003-02-14 Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator Abandoned AU2003245750A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35611402P 2002-02-14 2002-02-14
US60/356,114 2002-02-14
PCT/IE2003/000023 WO2003068245A1 (en) 2002-02-14 2003-02-14 Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator

Publications (1)

Publication Number Publication Date
AU2003245750A1 true AU2003245750A1 (en) 2003-09-04

Family

ID=27734608

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003245750A Abandoned AU2003245750A1 (en) 2002-02-14 2003-02-14 Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator

Country Status (2)

Country Link
AU (1) AU2003245750A1 (en)
WO (1) WO2003068245A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
IE20060710A1 (en) * 2005-09-28 2007-07-25 Alltracel Dev Services Ltd Use of polyanhydroglucronic acid
US20090176736A1 (en) * 2006-04-20 2009-07-09 Katsumi Dohura Pharmaceutical composition for conformational diseases
AU2012275265B2 (en) 2011-06-29 2017-05-04 Covidien Lp Dissolution of oxidized cellulose
US9138489B2 (en) 2012-05-31 2015-09-22 Covidien Lp Oxidized cellulose miczrospheres including visualization agents
US9271937B2 (en) 2012-05-31 2016-03-01 Covidien Lp Oxidized cellulose microspheres
US9168227B2 (en) 2012-05-31 2015-10-27 Covidien Lp Multi-encapsulated microspheres made with oxidized cellulose for in-situ reactions
US10040871B2 (en) 2012-06-28 2018-08-07 Covidien Lp Medical devices based on oxidized cellulose
US9447197B2 (en) 2012-06-28 2016-09-20 Covidien Lp Dissolution of oxidized cellulose and particle preparation by dispersion and neutralization
US9447196B2 (en) 2012-06-28 2016-09-20 Covidien Lp Dissolution of oxidized cellulose and particle preparation by solvent and non-solvent precipitation
US9499636B2 (en) 2012-06-28 2016-11-22 Covidien Lp Dissolution of oxidized cellulose and particle preparation by cross-linking with multivalent cations
US9782430B2 (en) 2013-03-15 2017-10-10 Covidien Lp Resorbable oxidized cellulose embolization solution
US10328095B2 (en) 2013-03-15 2019-06-25 Covidien Lp Resorbable oxidized cellulose embolization microspheres
US10413566B2 (en) 2013-03-15 2019-09-17 Covidien Lp Thixotropic oxidized cellulose solutions and medical applications thereof
US10449152B2 (en) 2014-09-26 2019-10-22 Covidien Lp Drug loaded microspheres for post-operative chronic pain
CN115607508B (en) * 2022-09-09 2024-03-15 杭州医学院 Nasal administration preparation for preventing and treating pneumonia caused by influenza A virus and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0956305T3 (en) * 1997-01-30 2002-01-07 Alpenstock Holdings Ltd cellulose Derivatives
CA2279648C (en) * 1997-01-30 2007-04-24 Alpenstock Holdings Limited Haemostatic aerosol composition
AU5061899A (en) * 1998-07-21 2000-02-14 Alpenstock Holdings Limited Anti-ulcer composition

Also Published As

Publication number Publication date
WO2003068245A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
AU2003245750A1 (en) Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator
AU2003202259A1 (en) Lipid compositions, production thereof and of esters
AU2003222083A1 (en) Acid and ester compounds and methods of using the same
AU2003206803A1 (en) Production of alkenones
AU2003295336A1 (en) Use of etodoclac to treat hyperplasia
AU2003230952A1 (en) Treatment of mucositis
AU2002367007A1 (en) Stabilisation of acid catalysts
AU2003205558A1 (en) Thioibotenic acid and derivatives thereof
AU7958100A (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
AU2003238605A1 (en) Dynamic representations of processes
AU2002952155A0 (en) Production of titania
AU2003289171A1 (en) Cosmetic preparation containing glycerylamino acid derivative
AU2003290249A1 (en) Purification of nanotubes
AU2003297597A1 (en) Benzimidazoles and analogs thereof as antibacterials
AU2003220029A1 (en) Application of foam to tissue products
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
AU2003266709A1 (en) Method of coagulating poly-3-hydroxyalkanoic acid
EP1572117A3 (en) Production of ubiquinones
AU2003297563A1 (en) Production of ubiquinones
AU2003208926A1 (en) Integration of at least two processes to re-use acid
AU2003260316A1 (en) Regulation of human hepsin
AU2003299746A1 (en) Total synthesis of daurichromenic acid
AU2003231527A1 (en) Novel derivatives of carnosic acid
AU2003208900A1 (en) L-carnitine for treatment of hearing loss
IL166778A0 (en) Derivatives of gl ycinergic r(+)-2-amino-3-hydroxypropanoic acid

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase